Events
Advertisement
Advertisement
Trending on OncLive
1
A New Era in Pancreatic Cancer Treatment: Daraxonrasib Shakes Up the Landscape
2
INCB161734 Combination Data Shape DAWN-303’s All-Comers Design in Frontline KRAS G12D-Mutated PDAC
3
Krascendo 1 Survival Data Position Divarasib to Reset Second-Line Standards and Fuel First-Line Combinations in KRAS G12C–Mutated NSCLC
4
OncLive Weekly News Quiz (10/30/2026): Did You Miss Crucial Prostate, HNSCC, and Hematologic Cancer Updates?
5